Crossref
Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study
Medical Research Journal · 15.01.2026 · 11
DOI: 10.5603/mrj.112316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Journal, online erschienen am 15.01.2026. Verfasst von Kamran Khan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khan, K. (2026). Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study. Medical Research Journal, 11(0). https://doi.org/10.5603/mrj.112316
Vancouver
Khan K. Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study. Medical Research Journal. 2026;11(0). doi:10.5603/mrj.112316
BibTeX
@article{Khan2026,
author = {Khan, Kamran},
title = {Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study},
journal = {Medical Research Journal},
year = {2026},
volume = {11},
number = {0},
doi = {10.5603/mrj.112316}
}
EUVIMED